Showing results (231-240 of 1,644) with videos related to
Sort By:
Pageof 165
Therapeutic Innovation & Regulatory Science|April 20, 2021
Evaluation of Data Errors and Monitoring Activities in a Trial in Japan Using a Risk-Based Approach Including Central Monitoring and Site Risk AssessmentHidenobu Kondo, Tomoaki Kamiyoshihara, Kenji Fujisawa, et al.Therapeutic Innovation & Regulatory Science|October 26, 2022
A Generalization of the Two Trials ParadigmGerd K RosenkranzTherapeutic Innovation & Regulatory Science|September 16, 2022
Regulatory Environment and Approvals in Cell and Gene Therapy Products Between Japan, the USA, and the EUYuya Sato, Shunsuke OnoTherapeutic Innovation & Regulatory Science|August 31, 2022
The Role of Master Protocols in Pediatric Drug DevelopmentRobert M Nelson, Laurie S Conklin, Wendy J Komocsar, et al.Therapeutic Innovation & Regulatory Science|January 12, 2022
Valuation and Returns of Drug Development Companies: Lessons for Bioentrepreneurs and InvestorsDaniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev, et al.Therapeutic Innovation & Regulatory Science|October 21, 2022
A Retrospective Analysis of Applications for Registration of Generic Medicines Processed by the Medicines Control Authority of ZimbabweBrilliant Tinashe Samunda, Tariro Sithole, Star KhozaTherapeutic Innovation & Regulatory Science|December 6, 2023
Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational StudyJumpei Saito, Hidefumi Nakamura, Miki Akabane, et al.Therapeutic Innovation & Regulatory Science|December 1, 2023
A Case Study Assessment on the Rationale for, and Relevance of, Non-Core Protocol DataZachary Smith, Kenneth GetzTherapeutic Innovation & Regulatory Science|January 9, 2024
Quantifying Site Burden to Optimize Protocol PerformanceMaria Florez, Zachary Smith, Zachary Olah, et al.Therapeutic Innovation & Regulatory Science|January 8, 2024
Aggregate IND Safety Reporting for Smaller Companies and ProgramsGreg Ball, Mengchun Li, Jim Buchanan, et al.Pageof 165